Acasă › Cancer pulmonar › Michigan › Lansing
Studii clinice pentru Cancer pulmonar în Lansing, MI
11 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Lansing (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- University of Michigan Health - Sparrow Lansing, Lansing
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- University of Michigan Health - Sparrow Lansing, Lansing
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- University of Michigan Health - Sparrow Lansing, Lansing
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
În curs de recrutareFaza 3
- University of Michigan Health - Sparrow Lansing, Lansing
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
În curs de recrutareFaza 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Michigan Health - Sparrow Lansing, Lansing
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Michigan Health - Sparrow Lansing, Lansing
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- University of Michigan Health - Sparrow Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Lansing
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Washington, DC41 studii
- Arlington, VA41 studii
- Chicago, IL41 studii
- Nashville, TN40 studii
- Baltimore, MD40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Lansing
- Cancer de prostată10 studii
- Cancer de sân10 studii
- Cancer pulmonar cu celule non-pătrate9 studii
- Cancer (toate tipurile)6 studii
- Cancer laringian5 studii
- Cancer de vezică urinară5 studii
- Tulburări de somnolență excesivă5 studii
- Cancer colorectal4 studii
- Cancer renal (carcinom cu celule renale)4 studii
- Cancer de colon4 studii
- Carcinom urotelial (cu celule de tranziție)4 studii
- Carcinom cu celule scuamoase de cap și gât4 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.